These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 16762988)

  • 1. Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure.
    Bernhardt WM; Câmpean V; Kany S; Jürgensen JS; Weidemann A; Warnecke C; Arend M; Klaus S; Günzler V; Amann K; Willam C; Wiesener MS; Eckardt KU
    J Am Soc Nephrol; 2006 Jul; 17(7):1970-8. PubMed ID: 16762988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protective effect of prolyl-hydroxylase inhibition against renal ischaemia requires application prior to ischaemia but is superior to EPO treatment.
    Wang Z; Schley G; Türkoglu G; Burzlaff N; Amann KU; Willam C; Eckardt KU; Bernhardt WM
    Nephrol Dial Transplant; 2012 Mar; 27(3):929-36. PubMed ID: 21742784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates ischemic acute kidney injury.
    Jamadarkhana P; Chaudhary A; Chhipa L; Dubey A; Mohanan A; Gupta R; Deshpande S
    Am J Nephrol; 2012; 36(3):208-18. PubMed ID: 22948183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against cisplatin-induced acute kidney injury.
    Yang Y; Yu X; Zhang Y; Ding G; Zhu C; Huang S; Jia Z; Zhang A
    Clin Sci (Lond); 2018 Apr; 132(7):825-838. PubMed ID: 29581249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of hypoxia-inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney.
    Rosenberger C; Rosen S; Shina A; Frei U; Eckardt KU; Flippin LA; Arend M; Klaus SJ; Heyman SN
    Nephrol Dial Transplant; 2008 Nov; 23(11):3472-8. PubMed ID: 18515655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxic preconditioning produces differential expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and its regulatory enzyme HIF prolyl hydroxylase 2 in neonatal rat brain.
    Jones NM; Lee EM; Brown TG; Jarrott B; Beart PM
    Neurosci Lett; 2006 Aug; 404(1-2):72-7. PubMed ID: 16828226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
    Knowles HJ; Tian YM; Mole DR; Harris AL
    Circ Res; 2004 Jul; 95(2):162-9. PubMed ID: 15192023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-prolyl hydroxylases and cardiovascular diseases.
    Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
    Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain.
    Schneider C; Krischke G; Keller S; Walkinshaw G; Arend M; Rascher W; Gassmann M; Trollmann R
    Brain Res; 2009 Jul; 1280():43-51. PubMed ID: 19450570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of hypoxia inducible factor (HIF-1α) in rat kidneys by iron chelation with the hydroxypyridinone, CP94.
    Baek JH; Reiter CE; Manalo DJ; Buehler PW; Hider RC; Alayash AI
    Biochim Biophys Acta; 2011; 1809(4-6):262-8. PubMed ID: 21558026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preischemic targeting of HIF prolyl hydroxylation inhibits fibrosis associated with acute kidney injury.
    Kapitsinou PP; Jaffe J; Michael M; Swan CE; Duffy KJ; Erickson-Miller CL; Haase VH
    Am J Physiol Renal Physiol; 2012 May; 302(9):F1172-9. PubMed ID: 22262480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
    Hewitson KS; Schofield CJ; Ratcliffe PJ
    Methods Enzymol; 2007; 435():25-42. PubMed ID: 17998047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats.
    Matsumoto M; Makino Y; Tanaka T; Tanaka H; Ishizaka N; Noiri E; Fujita T; Nangaku M
    J Am Soc Nephrol; 2003 Jul; 14(7):1825-32. PubMed ID: 12819242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of protective genes by cobalt ameliorates tubulointerstitial injury in the progressive Thy1 nephritis.
    Tanaka T; Matsumoto M; Inagi R; Miyata T; Kojima I; Ohse T; Fujita T; Nangaku M
    Kidney Int; 2005 Dec; 68(6):2714-25. PubMed ID: 16316346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of zinc preconditioning against renal ischemia reperfusion injury is dose dependent.
    Rao K; Sethi K; Ischia J; Gibson L; Galea L; Xiao L; Yim M; Chang M; Papa N; Bolton D; Shulkes A; Baldwin GS; Patel O
    PLoS One; 2017; 12(7):e0180028. PubMed ID: 28686686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient hypoxia-inducible factor activation in rat renal ablation and reduced fibrosis with L-mimosine.
    Yu X; Fang Y; Ding X; Liu H; Zhu J; Zou J; Xu X; Zhong Y
    Nephrology (Carlton); 2012 Jan; 17(1):58-67. PubMed ID: 21777345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model.
    Bernhardt WM; Gottmann U; Doyon F; Buchholz B; Campean V; Schödel J; Reisenbuechler A; Klaus S; Arend M; Flippin L; Willam C; Wiesener MS; Yard B; Warnecke C; Eckardt KU
    Proc Natl Acad Sci U S A; 2009 Dec; 106(50):21276-81. PubMed ID: 19934037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide-induced cross-tolerance against renal ischemia-reperfusion injury is mediated by hypoxia-inducible factor-2α-regulated nitric oxide production.
    He K; Chen X; Han C; Xu L; Zhang J; Zhang M; Xia Q
    Kidney Int; 2014 Feb; 85(2):276-88. PubMed ID: 24025643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inhibition of hypoxia-inducible factor prolyl 4-hydroxylase improves ventricular performance, remodeling, and vascularity after myocardial infarction in the rat.
    Bao W; Qin P; Needle S; Erickson-Miller CL; Duffy KJ; Ariazi JL; Zhao S; Olzinski AR; Behm DJ; Pipes GC; Jucker BM; Hu E; Lepore JJ; Willette RN
    J Cardiovasc Pharmacol; 2010 Aug; 56(2):147-55. PubMed ID: 20714241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic stabilization of hypoxia-inducible transcription factors protects developing mouse brain from hypoxia-induced apoptotic cell death.
    Trollmann R; Richter M; Jung S; Walkinshaw G; Brackmann F
    Neuroscience; 2014 Oct; 278():327-42. PubMed ID: 25162122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.